FDA
approval
· 2024-11-04
FDA Approved: FESOTERODINE FUMARATE — Supplemental Application (Amneal Pharmaceuticals LLC)
Summary
The FDA approved a supplemental application for Amneal's fesoterodine fumarate, a generic version of the overactive bladder medication.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FESOTERODINE FUMARATE (FESOTERODINE FUMARATE)